Filtros de búsqueda

Lista de obras de Candida Vitale

A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia

artículo científico publicado en 2014

Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia

artículo científico publicado en 2016

Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives

artículo científico publicado en 2019

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.

artículo científico publicado en 2015

Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib

artículo científico publicado en 2016

Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia

artículo científico publicado en 2015

CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results

scientific article published on 11 June 2019

CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia

artículo científico publicado en 2018

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

artículo científico publicado en 2021

Chronic lymphocytic leukemia therapy: new targeted therapies on the way

artículo científico publicado en 2016

Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide

artículo científico publicado en 2018

Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method.

artículo científico publicado en 2009

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.

artículo científico publicado en 2012

Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12

scientific article published on 26 June 2019

External validation of the accuracy of 'CLLflow score'

scientific article published on 14 September 2018

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia

artículo científico publicado en 2016

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

artículo científico publicado en 2011

Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

artículo científico publicado en 2016

Magic pills: new oral drugs to treat chronic lymphocytic leukemia.

artículo científico publicado en 2017

Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics

artículo científico publicado en 2016

Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies

artículo científico publicado en 2019

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy

scientific article published on 03 July 2020

Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia.

artículo científico publicado en 2017

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies

artículo científico publicado en 2017

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.

artículo científico publicado en 2015

The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia

scientific article published on 23 July 2020

The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting.

artículo científico publicado en 2014

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab

scientific article published on 16 September 2020

Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda